) during a measles epidemic in The Netherlands. MV RNA was detected n p 194 by reverse-transcriptase polymerase chain reaction in throat-swab specimens from 93% of the patients with clinical symptoms. MV RNA was detected from 5 days before until 12 days after the onset of symptoms. Most patients (88%) also secreted MV RNA in their urine until 5 weeks after the onset of symptoms. Oral fluid proved to be the most practical specimen for the simultaneous detection of MV-specific IgM antibody and viral RNA, which, together, confirmed 93% of measles cases. Viral RNA was also detected in oropharyngeal specimens from 3 healthy contact persons with serological proof of MV infection. The results of this study emphasize the feasibility of combined detection of viral RNA and MV-specific IgM antibodies in oropharyngeal specimens for the diagnosis of clinical and subclinical MV infection.
Clinical symptoms resembling those of measles may be caused by pathogens other than measles virus (MV) [1, 2] . In addition, asymptomatic MV infections are known to occur in immune persons [3, 4] . Laboratory investigations are therefore required to assess the significance of clinical and subclinical MV infections, especially when measles incidence is low, as it usually is in The Netherlands [5] .
Several methods have been developed as adjuncts to or alternatives for the detection of MV-specific IgM antibodies in serum, which is the reference standard for laboratory diagnosis of measles. For example, MVspecific IgM antibodies can be detected in oral-fluid specimens, albeit with lower sensitivity. Sensitivity of this method also depends on the time since onset of measles symptoms [6, 7] . Small blood specimens spotted and dried on filter paper proved to be very suitable not only for detection of MV-specific IgM antibody but also for the detection of viral RNA by reverse-transcriptase polymerase chain reaction (RT-PCR) [8] . RT-PCR of oropharyngeal specimens has also been proposed as a diagnostic test for measles [9] . Of interest, urinary shedding of MV was detected in vaccine recipients by RT-PCR, as described elsewhere [10] . Hence, RT-PCR-based detection of MV RNA during acute measles could serve a diagnostic purpose.
The present study examines direct detection of MV RNA in oral-fluid, throat-swab, and urine specimens by conventional and real-time RT-PCR, both before and after the onset of measles symptoms, and detection of MV-specific IgM antibody in blood and in oral fluid. All specimens were obtained during a measles epidemic [5] .
SUBJECTS, MATERIALS, AND METHODS
Study population. Cohort 1 includes biological spec-imens obtained from 26 families in which a member of the household had measles during a local measles outbreak that preceded an extensive epidemic in 1999-2000 [5] . Blood, oralfluid, throat-swab, and urine specimens were obtained from these children and their consenting household members ( ) within 2 weeks after the first reported case in their n p 101 schools [5] . Blood and oral-fluid specimens were obtained again 7 weeks later. Cohort 2 includes specimens obtained from patients with suspected measles cases who presented to different municipal health services during the epidemic. Data are presented for 93 persons from whom oral-fluid, throat-swab, and urine specimens were obtained and for whom an adequate clinical and epidemiological description was available. For 24 of these persons, blood specimens were obtained by finger puncture and were spotted onto filter paper. Cohort 3 (negative controls) includes oral-fluid specimens obtained from healthy adult persons ( ), from patients with confirmed rubella n p 65 or parvovirus B19 infection ( ), and from patients who n p 13 consulted their general practitioner for acute respiratory illness ( ). Informed consent to obtain clinical specimens for n p 116 the laboratory investigations was obtained from patients and their parents.
Specimens and handling. Serum specimens and filterpaper blood specimens were processed as described elsewhere [8] . Oral-fluid specimens were obtained by the patients' dribbling into a cup without specific collection devices and were diluted 1:4 in PBS. Throat-swab specimens were collected in viral transport medium [11] . Cells from the swab were sedimented (10 min of centrifugation at 350 g), and 20% of the cells were reconstituted in 200 mL of PBS. Urine specimens were centrifuged (10 min at 800 g), and the sediment of 1.5 mL of urine was reconstituted in 200 mL of PBS. RNA was purified from 200-mL specimens using the High Pure RNA isolation kit (Roche Diagnostics), modified by adding poly [A] to the lysis buffer (0.04 mg/mL) to improve the recovery of specific RNA.
RT-PCR protocols. Nested PCR was performed on 10% of purified RNA, according to an improved single-tube RT-PCR method, as described elsewhere for rhinoviruses [11] . MV N-gene RT primer pairs (nt 1001-1024 and nt 1570-1590) and nested primer pairs (nt 1177-1200 and nt 1449-1471) were selected for this purpose and have been described elsewhere [12] . RNA specimens were tested in duplicate and on 2 different days. Each test included negative control specimens and, as a positive control, a 3-log titration of RNA extracted from an MV reference strain (MV-BIL stock; TCID 50 /mL). Real- 4 2 ϫ 10 time PCR was performed using the Light Cycler Instrument (Roche). In brief, 10% of purified RNA was reverse transcribed with 4 mL of forward N-gene primer (nt 1172-1192; 75 pmol) and heated at 94ЊC for 2 min. After quenching on ice, 5 U of AMV-RT (Promega) was added in 6 mL of RT buffer [11] . The reaction mix was incubated for 60 min at 42ЊC. After heat denaturation at 94ЊC for 2 min, 2 mL of the cDNA was added to 18 mL of Light Cycler-DNA SYBR Green I master mix (4.5 mmol/L MgCl 2 ) in the presence of reverse N-gene primer (nt 1570-1590; 10 pmol) and Taqstart antibody (1.4 mmol/L; Clontech). Results are expressed as the equivalent of infectious virus (TCID 50 ), according to a titration of RNA extracted from MV-BIL. The detection limit of both PCR methods was estimated to be 0.003 TCID 50 MV-BIL. The specificity of the amplified RT-PCR products was confirmed by sequence analysis.
Antibody tests. Serum specimens and reconstituted filterpaper blood specimens were assayed for the presence of MVspecific IgM antibodies by use of a commercially available capture IgM assay (Meddens IgM comfort line; Biotest Seralc). MV-specific IgM antibodies in oral fluids (dilution, 1:10 to 1:320) were detected by an indirect IgM EIA, as described elsewhere for IgG antibodies in serum [13] . IgM EIA results were expressed as the reciprocals of dilutions of individual specimens showing 50% of the maximum OD at 450 nm, using a 4-parameter fit method [13] , and were qualified as positive if the absorbance values of the first 2 dilutions exceeded those of a panel of preimmune oral-fluid specimens plus 4 SD [7] . MVspecific serum IgG and virus-neutralizing antibodies were determined by an indirect antigen ELISA and by a neutralization test (NT), respectively [13] . Antibody titers are expressed in international units per milliliter (according to reference serum 66/202 [5 IU/mL], provided by National Institute for Biological Standards and Control, Potters Bar, UK). The detection limit was 0.02 IU/mL for IgG and 0.06 IU/mL for the NT.
RESULTS

MV-specific antibody detection in relation to disease development.
To evaluate different diagnostic methods, we obtained blood, throat-swab, oral-fluid, and urine specimens from 101 persons within 2 weeks after the first measles notification (cohort 1). This resulted in a collection of specimens from persons obtained before ( ) and after ( ) the n p 25 n p 27 onset of measles rash and from persons who were exposed but did not develop clinical symptoms (mainly the parents and older household members;
). None of the persons, exn p 49 cept 1 (day Ϫ1), had MV-specific serum antibodies before the onset of rash (figure 1). MV-specific IgM serum antibody responses peaked within 2 days after the onset of rash and declined to levels still detectable by indirect EIA 7-8 weeks after the onset of rash (figure 1A). MV-specific serum IgG and virusneutralizing antibody responses were also detected from the day the rash appeared ( figure 1B and 1C, respectively) . The antibody titers increased gradually during the first week after onset of rash and remained elevated afterward.
Detection of MV-specific IgM antibody in oral fluid. The IgM EIA did not detect MV-specific IgM antibodies in any of the oral-fluid specimens obtained before the onset of rash ( ). Of 57 specimens obtained after the onset of rash n p 24 (cohorts 1 and 2), 49 were IgM positive and 8 were IgM negative ( figure 2A) .
Detection of MV RNA in oral-fluid, throat-swab, and urine specimens. Figure 2B-2D shows the presence of MV-specific RNA in oral-fluid specimens (
) and in throat-swab specn p 53 imens ( ), as quantitatively determined by real-time RTn p 80 PCR ( figure 2B and 2C, respectively) , and in urine ( ), n p 71 as qualitatively determined by nested RT-PCR ( figure 2D ). Viral RNA was detected in all 3 specimen types as early as 5 days before the onset of rash and as late as 12 days after the onset of rash. Although the levels of specific RNA in individual oralfluid specimens varied to a large extent, a clear increase and decrease of virus load was observed in individual throat swabs, with RNA concentrations peaking near the day of the onset of rash.
Diagnostic tests of patients and healthy contact persons. MV-specific serum IgM antibodies were detected in all patients with suspected cases of measles who gave blood, irrespective of the EIA applied (table 1, tests 1 and 2). The capture IgM assay proved to be very suitable for analysis of reconstituted filter-paper blood specimens obtained from patients with sus- Table 1 . Diagnostic tests applied on blood, oral-fluid, throat-swab, and Subclinical MV infections in immune persons exposed to MV. A significant change of the specific IgG and virusneutralizing antibody response was observed in 8 of 33 investigated healthy contact persons (table 2, subjects 2 and 4-10). Three of these persons had MV-specific IgM antibodies present either in serum (subjects 8 and 10) or in oral fluid (subject 2). Of interest, MV RNA was detected in the oral-fluid specimen from subject 2. MV RNA was also detected in the oropharyngeal specimens from 2 other persons (subjects 1 and 3). One of these persons (subject 1) had MV-specific IgM antibodies in serum and in oral fluid, whereas the other person (subject 3) had remarkably high titers of MV-specific serum IgG and virusneutralizing antibodies, compared with the remainder of the investigated persons (table 2, subjects 13-33). Another person (subject 11) also showed high titers of specific serum IgG antibodies, but this person's specimens did not yield positive test results in the other assays.
DISCUSSION
Detection of MV in throat-swab specimens by RT-PCR recently has been shown to be a useful addition to blood serologic testing in the diagnosis of MV infection [9] . The present study has shown sensitive detection of MV RNA not only in throat-swab specimens but also in oral-fluid and urine specimens. The first results of a novel EIA specifically designed for the detection of MV-specific IgM antibody in oral fluid showed higher sensitivity (195%) than those of the one used in the present study [14] . The combined detection of viral RNA and MV-specific IgM antibody in oral fluid appears to provide high sensitivity and specificity for measles diagnosis. We applied both a conventional RT-PCR and a real-time RT-PCR, to assess the virus load in the oropharynx in relation to disease development. Viral RNA could be detected in throat-swab specimens as early as 5 days before and as late as 12 days after the onset of rash, with peak concentrations occurring near the first day of rash. These findings parallel the isolation of live virus through cocultivation on lymphoblastoid cell lines, which proved to be successful only for throat-swab specimens obtained no earlier than 3 days before and no later than 2 days after the onset of rash (table  1; data not shown). MV RNA previously has been found in urine specimens from persons vaccinated with live, attenuated measles vaccine [10] . Here, we report the presence of MV RNA in the majority (88%) of patients with measles as early as 5 days before and as late as 5 weeks after the onset of rash. It is not known to what extent a positive PCR result in urine late after measles onset still reflects the secretion of live virus or whether it reflects products of the virus or immune complexes long after the infection has been cleared. Of interest, MV RNA also was detected in few oral-fluid specimens obtained 17 weeks after onset of measles rash (data not shown). Because MV and other morbilliviruses may persist and cause encephalitic disease, the observations suggest that MV persists much longer in some infected persons than would be expected on the basis of clinical presentation.
Asymptomatic MV infections occur in healthy immune persons who are exposed to measles, as shown by the boosting of MV-specific serum IgG antibodies [3, 4] . To our knowledge, the presence of MV has not been demonstrated in such persons. Here, we present both serological (IgM, IgG, and NT) and virological (RT-PCR) evidence for such subclinical infections in reexposed persons. Most persons were reported to have had measles during an earlier epidemic [5, 13] . Five of these persons showed very high titers of MV-specific IgG serum antibodies shortly after their exposure to measles. In 3 of these persons, MV RNA was detected in the oropharynx. Five other healthy contact persons only showed significant antibody boosting (table 2). Of interest, MV-specific IgG and virus-neutralizing antibody titers, in the first serum specimens obtained from these particular persons, appeared to be quite low (0.22-0.88 IU/ mL), compared with those obtained from the remainder of the investigated persons. The presence of such low titers apparently does not confer protection against reinfection, as also indicated by other studies [3, 4] .
In conclusion, RT-PCR appears to be a versatile method in the diagnosis of measles. Our data indicate that RT-PCR reaches a sensitivity and positive predictive value close to 100% when applied to at least 2 clinical specimens (e.g., throat-swab and urine specimens; table 1). RT-PCR-based detection of the virus also proved to be specific and independent of the development of clinical symptoms. Furthermore, the longevity of the detection of MV RNA in urine specimens opens new possibilities to detect possible sources of infection and epidemiological chains of transmission by means of phylogenetic analysis [15] .
